Micro Emerging Active

LFCB completa la transizione a CDMO indipendente

Punteggio
0,3
Velocità
▲ 0,0
Articoli
1
Fonti
1

Riepilogo

An article belongs to this narrative if it discusses Lifecore Biomedical's transition to a standalone Contract Development and Manufacturing Organization (CDMO).

Articoli Correlati

Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit 60% by 2029

Yahoo Finance · Mar 22, 2026
Mixed

Fonti

Lifecore Biomedical CEO: Standalone CDMO Shift Complete, Utilization to Hit … Yahoo Finance

Cronologia

Ultimo aggiornamento Mar 22, 2026